Abstract:Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PABackground. Mitochondria is constantly exposed to reactive oxygen species (ROS), an important factor in carcinogenesis. Altered mitochondrial DNA (mtDNA) copy number in peripheral blood has been associated with increased risks of several cancers, including breast cancer. However, the association of mtDNA copy number with clinical outcomes of breast cancer has not been reported. This study aimed to assess the association of mtDNA copy number with second primary tumors (SPT) in long-term breast cancer survivors.Methods. We measured mtDNA by quantitative PCR in patients in 68 long-term breast cancer survivors with SPT, 100 long-term breast cancer survivors without SPT and 97 newly diagnosed breast cancer cases. Cases with and without SPT were matched by years since diagnosis, age at time of sample collection and race. Differences between mtDNA copy number among groups were analyzed using the Wilcoxon rank sum test.Results. MtDNA copy number was significantly higher in long-term breast cancer survivors (either with SPT or not SPT) compared with newly diagnosed breast cancer patients (Mean (SD), 1.03 ± 0.25 vs 0.95 ± 0.27; p = 0.005). We did not observe significant differences of mtDNA copy number between long-term survivors with SPT and without SPT. However, in stratified analyses by epidemiological and clinical variables, we observed lower mtDNA copy number in HER2-positive long-term survivors with SPT than those without SPT (0.84 ± 0.13 vs 1.27 ± 0.44; p = 0.010) and in pre-menopause long-term survivors with SPT than those without SPT (0.95 ± 0.20 vs 1.06 ± 0.22; p = 0.034). A borderline significance of mtDNA copy number between SPT and non-SPT ER-negative long-term survivors was also noted (0.90 ± 0.17 vs 1.18 ± 0.41, p = 0.056).Conclusion. Higher mtDNA copy number was found in long-term breast cancer survivors compared to newly diagnosed cases. There were significant associations between lower mtDNA copy number and SPT in long-term breast cancer survivors who are HER2+ or are pre-menopause. These results indicate a role of mtDNA copy number in long-term breast cancer survivorship.Citation Format: Miguel Santibanez, Alma Rodriguez, Michelle A. Hildebrandt, David W. Chang, Xifeng Wu. Mitochondrial DNA copy number and risk of second primary tumors in long-term breast cancer survivors. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3056. doi:10.1158/1538-7445.AM2015-3056

Constitutive Mitochondrial DNA Copy Number in Peripheral Blood of Melanoma Families with and Without CDKN2A Mutations.

Blood DNA methylation, nevi number, and the risk of melanoma

Melanoma Prone Families with CDK4 Germline Mutation: Phenotypic Profile and Associations with MC1R Variants.

Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.

Abstract A84: Reduced LINE-1 methylation in peripheral blood mononuclear cells is associated with risk of melanoma in families segregating CDKN2A germline mutations

CDKN2A Mutation in a Non-Fammm Kindred with Cancers at Multiple Sites Results in a Functionally Abnormal Protein

LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations.

Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families.

P069 Familial malignant melanoma: CDKN2A mutation-positive family tree

Phenocopies in Melanoma-Prone Families with Germ-Line CDKN2A Mutations

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families

Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and Without CDKN 2 A Mutations

Pediatric Melanoma in Melanoma-Prone Families.

Abstract 1126: Mitochondrial DNA Copy Number and Colorectal Cancer Risk: Results from the Shanghai Women's Health Study

Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.

Mitochondrial DNA Copy Number and Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma Risk in Two Prospective Studies.

Abstract 4509: Mitochondrial DNA Copy Number is Inversely Associated with Overall Survival in Non-Small Cell Lung Cancer

Estimating CDKN2A Mutation Carrier Probability among Global Familial Melanoma Cases Using GenoMELPREDICT.

Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades

Abstract 3056: Mitochondrial DNA Copy Number and Risk of Second Primary Tumors in Long-Term Breast Cancer Survivors

Mitochondrial Dna Copy Number And Risk Of Second Primary Tumors In Long-Term Breast Cancer Survivors